Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Radiation Dose to Primary Operator (RaySafe), Cardiac Catheterization |
Median effective radiation dose in microsievert (µSv) to the primary operator at the thyroid. This was measured using a RaySafe dosimeter to assess the radiation dose in each case. |
During each cardiac catheterization, an average of 90 minutes |
|
Primary |
Radiation Dose to Primary Operator (Luxel Dosimeter), Cardiac Catheterization |
Mean effective radiation dose in microsievert (µSv) to the primary operator at the thyroid. This was measured using a single Luxel dosimeter over all cases to assess the cumulative dose in the study arm. |
During each cardiac catheterization, an average of 90 minutes |
|
Primary |
Radiation Dose to Primary Operator, EP Procedure (Luxel) |
Mean effective radiation dose in microsievert (µSv) to the primary operator at the end of each EP implant procedure. A single Luxel dosimeter was and a cumulative dose was recorded. |
During each EP implant procedure, an average of 90 minutes |
|
Primary |
Radiation Dose to Primary Operator, EP Procedure (RaySafe) |
Median effective radiation dose in microsievert (µSv) to the primary operator at the end of each EP implant procedure using a RaySafe dosimeter. This is measured after each case. |
During each EP implant procedure, an average of 90 minutes duration |
|
Secondary |
Radiation Dose to Secondary Operator, Cardiac Catheterization (RaySafe) |
Median effective radiation dose (µSv) to the secondary operator at the thyroid. This was measured using a RaySafe dosimeter to assess the radiation dose in each case. |
During each cardiac catheterization, an average of 90 minutes |
|
Secondary |
Radiation Dose to Secondary Operator (Luxel Dosimeter), Cardiac Catheterization |
Mean effective radiation dose in microsievert (µSv) to the secondary operator at the thyroid. This was measured using a single Luxel dosimeter over all cases to assess the cumulative dose in the study arm. |
During each cardiac catheterization, an average of 90 minutes |
|
Secondary |
Radiation Dose to Nurse or Anesthetist, Cardiac Catheterization (RaySafe) |
Median effective radiation dose in microsievert (µSv) to the Nurse 0r Anesthetist at the thyroid. This was measured using a RaySafe dosimeter to assess the radiation dose in each case. |
During each cardiac catheterization, an average of 90 minutes |
|
Secondary |
Radiation Dose to Nurse or Anesthetist, Cardiac Catheterization (Luxel) |
Mean effective radiation dose in microsievert (µSv) to the Nurse or Anesthetist at the thyroid. This was measured using a single Luxel dosimeter over all cases to assess the cumulative dose in the study arm. |
During each cardiac catheterization, an average of 90 minutes |
|
Secondary |
Radiation Dose to Patient, Cardiac Catheterization |
Median radiation dose-area product (DAP) to the patient at the end of each cardiac catheterization case using data from a fluoroscopy machine. DAP is defined as the absorbed dose multiplied by the area irradiated micro-gray µGy*m^2. |
During each cardiac catheterization, an average of 90 minutes |
|
Secondary |
Radiation Dose in Cath Lab Room #5, Cardiac Catheterization |
Mean radiation dose microsieverts (µSv) at the end of each cardiac catheterization case at a standard location on the wall of the catheterization laboratory. This was measured using a single Luxel dosimeter over all cases to assess the cumulative dose in the study arm. |
During each cardiac catheterization, an average of 90 minutes |
|
Secondary |
Radiation Dose to Secondary Operator, EP Procedure (RaySafe) |
Mean effective radiation dose (µSv) to the secondary operator at the at the thyroid. This was measured using a RaySafe dosimeter to assess the radiation dose in each case. |
During each EP implant procedure, an average of 90 minutes |
|
Secondary |
Radiation Dose to Secondary Operator, EP Procedure (Luxel) |
Mean effective radiation dose (µSv) to the secondary operator at the at the thyroid. This was measured using a single Luxel dosimeter over all cases to assess the cumulative dose in the study arm. |
During each EP implant procedure, an average of 90 minutes |
|
Secondary |
Radiation Dose to Nurse or Anesthetist, EP Procedure (RaySafe) |
Median effective radiation dose in microsievert (µSv) to the primary operator at the thyroid. This was measured using a RaySafe dosimeter to assess the radiation dose in each case. |
During each EP implant procedure, an average of 90 minutes |
|
Secondary |
Radiation Dose to Nurse or Anesthetist, EP Procedure (Luxel) |
Mean effective radiation dose in microsievert (µSv) to the primary operator at the thyroid. This was measured using a single Luxel dosimeter over all cases to assess the cumulative dose in the study arm. |
During each EP implant procedure, an average of 90 minutes |
|
Secondary |
Radiation Dose to Patient, EP Procedure |
Mean radiation dose-area product (DAP) to the patient at the end of each EP implant procedure using data from a fluoroscopy machine. DAP is defined as the absorbed dose multiplied by the area irradiated (µGy*m^2) |
During each EP implant procedure, an average of 30-45 minutes of active radiation |
|
Secondary |
Radiation Dose in Cath Lab Room #5, EP Procedure |
Mean radiation dose (µSv) at the end of each EP implant procedure at a standard location on the wall of the catheterization laboratory. This was measured using a single Luxel dosimeter over all cases to assess the cumulative dose in the study arm. |
During each EP implant procedure, an average of 90 minutes |
|